Steve Elms's Net Worth

$812 Million

Estimate Recalculated Feb 28, 2024 09:03PM EST

Who is Steve Elms?

Steve Elms has an estimated net worth of $812 Million. This is based on reported shares across multiple companies, which include MAP Pharmaceuticals, Inc., Zeltiq Aesthetics Inc, CEMPRA, INC., ViewRay, Inc., Zosano Pharma Corp, Esperion Therapeutics, Inc., ADMA BIOLOGICS, INC., Loxo Oncology, Inc., AGILE THERAPEUTICS INC, Elevation Oncology, Inc., Syros Pharmaceuticals, Inc., Cidara Therapeutics, Inc., T2 Biosystems, Inc., TRANSENTERIX INC., SUNESIS PHARMACEUTICALS INC, Durata Therapeutics, Inc., Versartis, Inc., Marker Therapeutics, Inc., AMBIT BIOSCIENCES CORP, PERNIX THERAPEUTICS HOLDINGS, INC., INTERPHARM HOLDINGS INC, and Adams Respiratory Therapeutics, Inc..

SEC CIK

Steve Elms's CIK is 0001250195

Past Insider Trading and Trends

2014 was Steve Elms's most active year for acquiring shares with 22 total transactions. Steve Elms's most active month to acquire stocks was the month of May. 2014 was Steve Elms's most active year for disposing of shares, totalling 17 transactions. Steve Elms's most active month to dispose stocks was the month of April. 2011 saw Steve Elms paying a total of $10,000,003.00 for 769,231 shares, this is the most they've acquired in one year. In 2019 Steve Elms cashed out on 2,089,919 shares for a total of $491,130,965.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Loxo Oncology, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-50.00%
-2.04M
$235.00
-$479,146,200.00
2.04M
Feb 15
Form 4
-40.71%
-1.40M
$179.43
-$251,202,000.00
2.04M
Jul 10
Form 4
0
0
Jun 13
Form 4
-6.78%
-250.00K
$80.50
-$20,125,000.00
3.44M
Dec 19
Form 4
-11.94%
-500.00K
$75.00
-$37,500,000.00
3.69M
Nov 22
Form 4
0
0
Jun 22
Form 4
+3.97%
160K
$31.00
$4,960,000.00
4.19M
Jan 10
Form 4
0
0
Jun 10
Form 4
+6.13%
232.56K
$21.50
$4,999,997.00
4.03M
May 17
Form 4
+0.01%
200
$27.50
$5,500.00
3.8M
Dec 11
Form 4
+7.50%
265K
$26.50
$7,022,500.00
3.8M
Nov 17
Form 4
+1.13%
78.67K
$27.56
$2,175,022.78
7.06M
Nov 12 - Nov 13
Form 4
0
0
Jul 28
Form 4
+1,729.55%
3.26M
$13.00
$5,370,001.00
3.45M
Aug 6
Form 4
+1,729.55%
3.26M
$13.00
$5,370,001.00
3.45M
Aug 6
Form 4
0
0
Jul 31
Form 3
0
0
Form 3
0
0
No matching records found

Zeltiq Aesthetics Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-27.55%
-990.77K
2.61M
Jan 23
Form 4
-13.78%
-575.00K
$12.22
-$7,026,500.00
3.6M
Nov 14
Form 4
+22.60%
769.23K
$13.00
$10,000,003.00
4.17M
Oct 24
Form 3
0
0
No matching records found

CEMPRA, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+58.37%
1.21M
$6.00
$7,281,978.00
3.29M
Feb 7
Form 3/A
0
0
No matching records found

ViewRay, Inc. (VRAYQ) Snapshot price: $0.000001

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
0
0
No matching records found

Zosano Pharma Corp No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+200.00%
15K
22.5K
Jun 10
Form 4
7.5K
7.5K
Jun 25
Form 4
0
0
Jun 3
Form 4
+34.00%
689.65K
$1.45
$999,999.75
2.72M
Dec 2
Form 4
0
0
Jan 2
Form 4
+26.79%
428.57K
$3.50
$1,499,998.50
2.03M
Apr 11
Form 4
0
0
May 17
Form 3/A
0
0
Form 3
0
0
No matching records found